Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial
Titel:
Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial
Auteur:
Reifsnider, Odette S. Kansal, Anuraag R. Wanner, Christoph Pfarr, Egon Koitka-Weber, Audrey Brand, Sarah B. Stargardter, Matthew Wang, Cheng Kuti, Effie Ustyugova, Anastasia